<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011420'>Death</z:hpo>-associated protein kinase (DAP-Kinase) is a novel serine/threonine kinase whose expression is required for gamma interferon-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>A previous study suggested that DAP-Kinase expression may be lost epigenetically in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines, because treatment of several nonexpressing cell lines with <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> resulted in the expression of DAP-Kinase </plain></SENT>
<SENT sid="2" pm="."><plain>Using methylation-specific polymerase chain reaction (MSP), we examined the DAP-Kinase CpG island for hypermethylation in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> lymphocytes and lymphoblastoid cell lines are unmethylated in the 5' CpG island of DAP-Kinase </plain></SENT>
<SENT sid="4" pm="."><plain>However, in <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e> samples, <z:hpo ids='HP_0000001'>all</z:hpo> Burkitt's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> and 84% of the B-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphomas</z:hpo> were hypermethylated in the DAP-Kinase CpG island </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, none of the T-cell non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> samples and 15% or less of <z:hpo ids='HP_0001909'>leukemia</z:hpo> samples examined had hypermethylated DAP-Kinase alleles </plain></SENT>
<SENT sid="6" pm="."><plain>U937, an unmethylated, DAP-Kinase-expressing <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line, was treated with gamma interferon and underwent <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; however, Raji, a fully methylated, DAP-Kinase nonexpressing Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, only did so when treated with <z:chebi fb="0" ids="50131">5-aza-2'-deoxycytidine</z:chebi> followed by gamma interferon </plain></SENT>
<SENT sid="7" pm="."><plain>Our findings in cell lines and <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumors</z:e> suggest that hypermethylation of the DAP-Kinase gene and loss of gamma interferon-mediated <z:mpath ids='MPATH_3'>apoptosis</z:mpath> may be important in the development of B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and may provide a promising biomarker for B-cell-lineage <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
</text></document>